Phase 2 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old
- You have not previously received any treatment (local or systemic) for liver cancer
- Your liver function is at an acceptable level, based on a scoring system called Child-Pugh (score of 7 or below — confirm with trial site)
- You are able to carry out daily activities with little or no limitation (based on a performance scale called ECOG PS 0–1 — confirm with trial site)
- You do not have serious diseases affecting your heart, lungs, brain, or kidneys
- Scans show that your liver tumor could be surgically removed, but carries a high risk of coming back, and the cancer has not spread to distant parts of the body (confirm with trial site)
- Your liver cancer diagnosis has been confirmed by a tissue sample (biopsy)
- A specialist computer model — using information from your tissue sample, scans, and genetic data — suggests you may benefit from the combination treatment used in this trial (confirm with trial site)
Who may not be able to join:
- Women who are pregnant or breastfeeding
- People who have a condition that may prevent the study medication from being properly absorbed or processed by the body (for example, severe vomiting, long-term diarrhea, or bowel blockage)
- People who have had bleeding in their stomach or digestive system in the past 4 weeks, or who are considered at high risk of such bleeding
- People who currently have an active infection
- People with other significant health or test result abnormalities that could affect safety (confirm with trial site)
- People who are unable to follow the trial's treatment schedule or attend follow-up appointments as required
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Median event-free survival (EFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.